RAPADOCS (RAPADOCS)

Rapamycin + Doxycycline. Independently validated for strong lifespan effects (Rapa 37%, Doxy 95%). Both FDA-approved drugs, a well-validated mTOR inhibitor combined with a popular antibiotic and anti-inflammatory. Highly promising longevity cocktail with a fast path to market, allowing you to invest in longevity interventions today that may fuel your longevity tomorrow. Launched by Rapamycin Longevity Lab in collaboration with the Center for Healthy Longevity, National University of Singapore.